Task: Answer the multiple-choice question.
Question: Which drug exhibits a -1.569% hERG inhibition at 10uM?
Constraint: You must select none, one or more options from a, b, or c without using any additional words.
Options:
a: C/C(=N\NC(=O)Cc1ccc(Cl)cc1)c1cccnc1
b: CCc1ccc(C2CC(c3ccccc3C)n3nc(N)nc3N2)cc1
c: CCNC(=S)Nc1cccc([N+](=O)[O-])c1
Answer: b. CCc1ccc(C2CC(c3ccccc3C)n3nc(N)nc3N2)cc1
{#Task|Problem statement!}: Answer the {#multiple choice|multiple-choice|MCQ!} question.
{#Question|Query!}: Which {#compound|drug!} {#has|exhibits!} a {herg_central_at_10uM#}{herg_central_at_10uM__units} {herg_central_at_10uM__names__noun}?
Constraint: You must select none, one or more options from {%multiple_choice_enum%2-5%aA1} without using any {#other|additional!} words.
Options:
{SMILES%herg_central_at_10uM%}
Answer: {%multiple_choice_result}. {SMILES#}
CCc1ccc(C2CC(c3ccccc3C)n3nc(N)nc3N2)cc1
CCc1ccc(C2CC(c3ccccc3C)n3nc(N)nc3N2)cc1
5-(4-ethylphenyl)-7-(2-methylphenyl)-4,5,6,7-tetrahydro-[1,2,4]triazolo[1,5-a]pyrimidin-2-amine